Bone Biologics Corp (BBLG)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.10M
Last updated: Nov 17, 2026 at 11:03 AM ET
Bone Biologics Corp (BBLG) Earnings: Report Dates and Results
Bone Biologics (BBLG) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Bone Biologics reported EPS of -$0.17, above the -$0.19 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
BBLG has an expected report date of Mar 1, 2027.
Earnings History
Of the 21 quarters below that had an estimate, BBLG beat 13, missed 7 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 295.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.17 | -$0.19 | -$0.19 - -$0.19 | +10.53% | Beat | N/A | 1 | 0 up, 1 down | Oct 26, 2026 |
| Jun 30, 2026 | -$0.43 | -$0.39 | -$0.39 - -$0.39 | -10.26% | Miss | N/A | 1 | 1 up, 0 down | Aug 14, 2026 |
| Mar 31, 2026 | -$0.43 | -$0.54 | -$0.54 - -$0.54 | +20.37% | Beat | N/A | 1 | 0 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$0.63 | -$0.34 | -$0.34 - -$0.34 | -85.29% | Miss | N/A | 1 | 1 up, 0 down | Mar 2, 2026 |
| Sep 30, 2025 | -$0.37 | -$1.23 | -$1.23 - -$1.23 | +69.92% | Beat | N/A | 1 | 1 up, 0 down | Nov 14, 2025 |
| Jun 30, 2025 | -$1.33 | -$0.58 | -$0.58 - -$0.58 | -129.31% | Miss | N/A | 1 | 1 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$0.32 | -$7.68 | N/A | +95.84% | Beat | N/A | N/A | 1 up, 0 down | May 12, 2025 |
| Dec 31, 2024 | -$2.88 | -$3.90 | -$3.90 - -$3.90 | +26.15% | Beat | N/A | 1 | 0 up, 1 down | Mar 5, 2025 |
| Sep 30, 2024 | -$14.22 | -$3.60 | -$3.60 - -$3.60 | -295.00% | Miss | N/A | 1 | 1 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$4.02 | -$8.34 | -$8.34 - -$8.34 | +51.80% | Beat | N/A | 1 | 0 up, 0 down | Aug 9, 2024 |
| Mar 31, 2024 | -$7.86 | -$7.60 | -$7.60 - -$7.60 | -3.40% | Miss | N/A | 1 | 0 up, 0 down | Apr 4, 2024 |
| Dec 31, 2023 | -$2.47 | -$5.60 | -$5.60 - -$5.60 | +55.89% | Beat | N/A | 1 | 0 up, 0 down | Feb 20, 2024 |
| Sep 30, 2023 | -$29.28 | -$145.92 | N/A | +79.93% | Beat | N/A | 1 | 1 up, 0 down | Nov 14, 2023 |
| Jun 30, 2023 | -$81.12 | -$72.00 | N/A | -12.67% | Miss | N/A | 1 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$331.20 | -$100.80 | N/A | -228.57% | Miss | N/A | 2 | 0 up, 1 down | May 15, 2023 |
| Dec 31, 2022 | -$0.18 | -$0.22 | -$0.29 - -$0.16 | +18.18% | Beat | N/A | 2 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$172.80 | -$216.00 | -$360.29 - -$72.06 | +20.00% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$72.00 | -$172.80 | N/A | +58.33% | Beat | N/A | 1 | 0 up, 0 down | Aug 11, 2022 |
| Mar 31, 2022 | -$100.80 | -$288.00 | N/A | +65.00% | Beat | N/A | N/A | 0 up, 0 down | May 13, 2022 |
| Dec 31, 2021 | -$0.05 | -$0.17 | N/A | +70.59% | Beat | N/A | N/A | 0 up, 0 down | Mar 15, 2022 |
| Sep 30, 2021 | -$0.17 | -$0.17 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 16, 2021 |
| Jun 30, 2021 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 15, 2021 |
| Dec 31, 2020 | -$53.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2020 |
| Sep 30, 2020 | -$194.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 |
| Jun 30, 2020 | -$187.97 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2020 |
| Mar 31, 2020 | -$295.24 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2020 |
| Dec 31, 2019 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 27, 2020 |
| Sep 30, 2019 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2019 |
| Jun 30, 2019 | -$0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2019 |
| Mar 31, 2019 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2019 |
| Dec 31, 2018 | -$0.38 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2019 |
| Sep 30, 2018 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 16, 2018 |
| Jun 30, 2018 | -$0.29 | N/A | N/A | N/A | N/A | -1550.0% | N/A | N/A | Aug 14, 2018 |
| Mar 31, 2018 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 2, 2018 |
| Dec 31, 2017 | -$2,160.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2017 |
| Sep 30, 2017 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2017 |
| Jun 30, 2017 | $0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2017 |
| Mar 31, 2017 | -$0.08 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2017 |
| Dec 31, 2016 | -$4,523.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2017 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.65, after -$28.98 the year before. It was -$20,348.68 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.65 | N/A |
| Dec 31, 2024 | -$28.98 | N/A |
| Dec 31, 2023 | -$444.07 | N/A |
| Dec 31, 2022 | -$345.78 | N/A |
| Dec 31, 2021 | -$0.35 | N/A |
| Dec 31, 2020 | -$731.35 | N/A |
| Dec 31, 2019 | -$0.47 | N/A |
| Dec 31, 2018 | -$0.76 | N/A |
| Dec 31, 2017 | -$2,160.12 | N/A |
| Dec 31, 2016 | -$20,348.68 | N/A |
Frequently Asked Questions About BBLG
When is Bone Biologics's next earnings date?
Bone Biologics's next earnings report is expected for Mar 1, 2027.
Did BBLG beat earnings estimates last quarter?
Yes. Bone Biologics reported EPS of -$0.17 for the quarter ended Sep 30, 2026, above the -$0.19 estimate, a 10.53% surprise.
What EPS do analysts expect from BBLG next quarter?
The consensus EPS estimate for Bone Biologics for the quarter ending Dec 31, 2026 is -$0.15 from 3 analysts.
How often does BBLG beat earnings estimates?
Bone Biologics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -0.26%.
BBLG pages: Overview, Earnings, Forecast, Financials, Competitors